These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18623218)

  • 21. Nursing considerations for optimal outpatient management of adult patients with leukemia treated with clofarabine.
    Dressel A; Kwari M; McGreal AM
    Clin J Oncol Nurs; 2011 Feb; 15(1):E13-23. PubMed ID: 21278032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of anti-cancer action and pharmacology of clofarabine.
    Zhenchuk A; Lotfi K; Juliusson G; Albertioni F
    Biochem Pharmacol; 2009 Dec; 78(11):1351-9. PubMed ID: 19576186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.
    Faderl S; Gandhi V; Keating MJ; Jeha S; Plunkett W; Kantarjian HM
    Cancer; 2005 May; 103(10):1985-95. PubMed ID: 15803490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
    Bonate PL; Arthaud L; Cantrell WR; Stephenson K; Secrist JA; Weitman S
    Nat Rev Drug Discov; 2006 Oct; 5(10):855-63. PubMed ID: 17016426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute myeloid leukemia and ischemic heart disease successful first line treatment with clofarabine as single agent.
    Capria S; Trisolini SM; Matturro A; Santini L; Cardarelli L; Foà R; Meloni G
    Leuk Res; 2009 Dec; 33(12):e230-1. PubMed ID: 19646753
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cladribine for 13 cases refractory high-risk children Langerhans cell histiocytosis].
    Hu T; Liu R; Li J; Cao J; Zhang L; Li J; Fan W; Zhong D; Shi X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):985-9. PubMed ID: 25417874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How I treat Langerhans cell histiocytosis.
    Allen CE; Ladisch S; McClain KL
    Blood; 2015 Jul; 126(1):26-35. PubMed ID: 25827831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs.
    Bagley RG; Roth S; Kurtzberg LS; Rouleau C; Yao M; Crawford J; Krumbholz R; Lovett D; Schmid S; Teicher BA
    Int J Oncol; 2009 May; 34(5):1329-40. PubMed ID: 19360345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clofarabine for treatment of acute lymphoblastic leukaemia in adults.
    Rodríguez Vargas B; Sánchez Cuervo M; Bermejo Vicedo T
    Farm Hosp; 2011; 35(1):47-9. PubMed ID: 20673734
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of clofarabine in acute myeloid leukemia.
    Ghanem H; Kantarjian H; Ohanian M; Jabbour E
    Leuk Lymphoma; 2013 Apr; 54(4):688-98. PubMed ID: 22957815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study.
    Lu A; Fang Y; Du X; Li Y; Cai Z; Yu K; Zhao L; Wang B; Wu J; Cheng Y; Zuo Y; Jia Y; Tan F; Ding L; Lu J; Zhang L; Huang X
    Blood Cancer J; 2016 Feb; 6(2):e400. PubMed ID: 26918364
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clofarabine in leukemia.
    Ghanem H; Jabbour E; Faderl S; Ghandhi V; Plunkett W; Kantarjian H
    Expert Rev Hematol; 2010 Feb; 3(1):15-22. PubMed ID: 21082931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy.
    Racil Z; Toskova M; Dvorakova D; Jeziskova I; Razga F; Buresova L; Timilsina S; Mayer J
    Am J Hematol; 2012 Feb; 87(2):211-3. PubMed ID: 22052688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience.
    Biswas G; Khadwal A; Arora B; Bhagwat R; Banavali SD; Nair CN; Pai SK; Kurkure PA; Parikh PM
    Indian J Cancer; 2007; 44(4):137-41. PubMed ID: 18322355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful management with clofarabine for refractory leukaemia in a young adult with chronic renal failure.
    Sudour H; Kimmoun A; Contet A; Clement L; Salmon A; Schmitt C; Chastagner P
    Am J Hematol; 2011 Mar; 86(3):321-3. PubMed ID: 21328440
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
    McGregor BA; Brown AW; Osswald MB; Savona MR
    Am J Hematol; 2009 Apr; 84(4):228-30. PubMed ID: 19260120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine.
    Büchler T; Cervinek L; Belohlavek O; Kantorova I; Mechl M; Nebesky T; Vorlicek J; Adam Z
    Pediatr Blood Cancer; 2005 Mar; 44(3):286-8. PubMed ID: 15481071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clofarabine for myelodysplastic syndromes.
    Tiu RV; Traina F; Sekeres MA
    Expert Opin Investig Drugs; 2011 Jul; 20(7):1005-14. PubMed ID: 21591997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases.
    Adam Z; Szturz P; Vaníček J; Moulis M; Pour L; Krejčí M; Hájek R; Mayer J
    Acta Oncol; 2013 Jun; 52(5):994-1001. PubMed ID: 22937955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.